Protection of Omicron Sub-Lineage Infection Against Reinfection with Another Omicron Sub-Lineage: Systematic Review, Meta-Analysis, and Meta-Regression — Worldwide, 2022

Protection of Omicron Sub-Lineage Infection Against Reinfection with Another Omicron Sub-Lineage: Systematic Review, Meta-Analysis, and Meta-Regression — Worldwide, 2022–2023

Published:2024 Issue:26 Volume:6 Page:624-628
ISSN:2097-3101
Container-title:China CDC Weekly
language:en
Short-container-title:

Author:

Guo Xu, ,Cheng Zuyao,Li Junhong,Song Yudan,Zheng Hui,Wang Yamin,Ma Chao,Feng Zijian,

Publisher

Chinese Center for Disease Control and Prevention

Link

https://weekly.chinacdc.cn/en/article/pdf/preview/10.46234/ccdcw2024.103

Reference10 articles.

1. Leung K, Lau EHY, Wong CKH, Leung GM, Wu JT. Estimating the transmission dynamics of SARS-CoV-2 Omicron BF.7 in Beijing after adjustment of the zero-COVID policy in November-December 2022. Nat Med 2023;29(3):579 − 82. http://dx.doi.org/10.1038/s41591-023-02212-y.

2. Diani S, Leonardi E, Cavezzi A, Ferrari S, Iacono O, Limoli A, et al. SARS-CoV-2-the role of natural immunity: a narrative review. J Clin Med 2022;11(21):6272.

3. Wu NN, Joyal-Desmarais K, Ribeiro PAB, Vieira AM, Stojanovic J, Sanuade C, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med 2023;11(5):439 − 52.

4. Tan CY, Chiew CJ, Pang D, Lee VJ, Ong B, Lye DC, et al. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic Omicron BA. 4, BA.5, and XBB reinfections in Singapore: a national cohort study. Lancet Infect Dis 2023;23(7):799 − 805.

5. Chemaitelly H, Tang P, Coyle P, Yassine HM, Al-Khatib HA, Smatti MK, et al. Protection against reinfection with the Omicron BA. 2.75 subvariant. N Engl J Med 2023;388(7):665 − 7.